Bavituximab, referred to as TRWH-783, represents a exciting treatment technique targeting phosphatidylserine (PS). PS is normally an inside lipid located on cell membranes; however, it's frequently shown on the surface of cancer cells and dying cells, acting as a “eat me” signal for immune cells. This antibody precisely targets PS, trying to im